Associations Among Human Papillomavirus, Inflammation, and Fatigue in Patients with Head and Neck Cancer

Overview

Journal Cancer

Publisher Wiley

Specialty Oncology

Date 2018 May 10

PMID 29742284

Citations 23

Authors

Canhua Xiao

Jonathan J Beitler

Kristin A Higgins

Toby Glazer

Linh Kha Huynh

Sudeshna Paul

Jennifer C Felger

Evanthia C Wommack

Nabil F Saba

Dong M Shin

Deborah W Bruner

Andrew H Miller

Affiliations

Soon will be listed here.

Abstract

Background: Human papillomavirus (HPV) infection has contributed to an increased incidence of squamous cell carcinoma of the head and neck (SCCHN). Fatigue is a major side effect of SCCHN and its treatment. However, to the authors' knowledge, the association between HPV and fatigue has not been examined to date, nor is it known whether HPV influences biological mechanisms of fatigue, including inflammation.

Methods: Patients with SCCHN who were without distant metastasis were assessed at baseline (pre-radiotherapy) and 1 month and 3 months postradiotherapy. Fatigue was measured using the Multidimensional Fatigue Inventory. Peripheral inflammation was assessed by plasma C-reactive protein (CRP), interleukin 1 receptor antagonist (IL-1ra), soluble tumor necrosis factor receptor 2 (sTNFR2), and IL-6. Mixed effect models were used to examine associations.

Results: A total of 94 patients who were newly diagnosed were enrolled; 53% had HPV-related tumors. Patients with HPV-unrelated tumors had higher fatigue and higher plasma CRP, sTNFR2, and IL-6 over time, especially at baseline and 3 months after intensity-modulated radiotherapy compared with those with HPV-related tumors (all P < .05). However, fatigue and plasma sTNFR2 increased more significantly from baseline to 1 month after radiotherapy in the HPV-related group compared with the HPV-unrelated group (both P < .01). Controlling for significant covariates, HPV status and inflammation were found to be independent predictors of fatigue over time.

Conclusions: HPV status is an important marker of vulnerability to the behavioral and immune consequences of SCCHN and its treatment, providing support for different symptom management strategies. Special emphasis should be placed on addressing marked persistent fatigue in patients with HPV-unrelated tumors, whereas attention should be paid to the large increases in fatigue during treatment among patients with HPV-related tumors. Cancer 2018. © 2018 American Cancer Society.

Citing Articles

A protocol for the longitudinal investigation of cancer related fatigue in head and neck cancer with an emphasis on the role of physical activity.

Narasimhan P, Levy A, Rogers S, Schache A, Patterson J, Williams N PLoS One. 2024; 19(8):e0308400.

PMID: 39141642 PMC: 11324130. DOI: 10.1371/journal.pone.0308400.

Bolnykh I, Patterson J, Harding S, Watson L, Lu L, Hurley K J Cancer Surviv. 2024; .

PMID: 38421499 DOI: 10.1007/s11764-024-01554-x.

Type I interferons, inflammation, and fatigue in a longitudinal RNA study of women with breast cancer.

Bower J, Ganz P, Irwin M, Crespi C, Petersen L, Asher A Brain Behav Immun. 2024; 118:312-317.

PMID: 38325563 PMC: 11095951. DOI: 10.1016/j.bbi.2024.02.003.

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis.

Kentnowski M, Cortez A, Mazurek A, Mrochem-Kwarciak J, Hebda A, Kacorzyk U Sci Rep. 2023; 13(1):21226.

PMID: 38040848 PMC: 10692143. DOI: 10.1038/s41598-023-48506-6.

Sharp L, Watson L, Lu L, Harding S, Hurley K, Thomas S Cancers (Basel). 2023; 15(19).

PMID: 37835558 PMC: 10571913. DOI: 10.3390/cancers15194864.

References

Xiao C, Miller A, Felger J, Mister D, Liu T, Torres M . Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors. Psychol Med. 2017; 47(10):1733-1743. DOI: 10.1017/S0033291717000150. View

Prue G, Rankin J, Allen J, Gracey J, Cramp F . Cancer-related fatigue: A critical appraisal. Eur J Cancer. 2006; 42(7):846-63. DOI: 10.1016/j.ejca.2005.11.026. View

Ang K, Harris J, Wheeler R, Weber R, Rosenthal D, Nguyen-Tan P . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363(1):24-35. PMC: 2943767. DOI: 10.1056/NEJMoa0912217. View

Truong M, Zhang Q, Rosenthal D, List M, Axelrod R, Sherman E . Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology.... Int J Radiat Oncol Biol Phys. 2016; 97(4):687-699. PMC: 5303682. DOI: 10.1016/j.ijrobp.2016.08.003. View

Schmidt M, Chang-Claude J, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K . Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern. J Cancer Surviv. 2011; 6(1):11-9. DOI: 10.1007/s11764-011-0197-3. View

Fang F, Liu Y, Tang Y, Wang C, Ko S . Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer. 2004; 100(2):425-32. DOI: 10.1002/cncr.20010. View

Park H, Janjan N, Mendoza T, Lin E, Vadhan-Raj S, Hundal M . Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2009; 75(3):775-81. PMC: 3090722. DOI: 10.1016/j.ijrobp.2008.11.027. View

Felger J, Li Z, Haroon E, Woolwine B, Jung M, Hu X . Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2015; 21(10):1358-65. PMC: 4862934. DOI: 10.1038/mp.2015.168. View

Rosenthal D, Mendoza T, Fuller C, Hutcheson K, Wang X, Hanna E . Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014; 120(13):1975-84. PMC: 4095802. DOI: 10.1002/cncr.28672. View

10.

Zhou X, Fragala M, McElhaney J, Kuchel G . Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care. 2010; 13(5):541-7. PMC: 2955626. DOI: 10.1097/MCO.0b013e32833cf3bc. View

11.

Xiao C, Hanlon A, Zhang Q, Ang K, Rosenthal D, Nguyen-Tan P . Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncol. 2012; 49(4):360-6. PMC: 3924732. DOI: 10.1016/j.oraloncology.2012.10.004. View

12.

Xiao C, Zhang Q, Nguyen-Tan P, List M, Weber R, Ang K . Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology.... Int J Radiat Oncol Biol Phys. 2016; 97(4):667-677. PMC: 5266672. DOI: 10.1016/j.ijrobp.2016.07.020. View

13.

Ringash J, Fisher R, Peters L, Trotti A, OSullivan B, Corry J . Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART). Int J Radiat Oncol Biol Phys. 2016; 97(4):678-686. DOI: 10.1016/j.ijrobp.2016.03.017. View

14.

Gulliford S, Miah A, Brennan S, McQuaid D, Clark C, Partridge M . Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother Oncol. 2012; 104(2):205-12. DOI: 10.1016/j.radonc.2012.07.005. View

15.

Siegel R, Miller K, Jemal A . Cancer statistics, 2016. CA Cancer J Clin. 2016; 66(1):7-30. DOI: 10.3322/caac.21332. View

16.

Smets E, Garssen B, Bonke B, de Haes J . The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39(3):315-25. DOI: 10.1016/0022-3999(94)00125-o. View

17.

Xiao C, Beitler J, Higgins K, Conneely K, Dwivedi B, Felger J . Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy. Brain Behav Immun. 2015; 52:145-152. PMC: 4867228. DOI: 10.1016/j.bbi.2015.10.016. View

18.

Solberg Nes L, Ehlers S, Patten C, Gastineau D . Self-regulatory fatigue in hematologic malignancies: impact on quality of life, coping, and adherence to medical recommendations. Int J Behav Med. 2011; 20(1):13-21. PMC: 4454389. DOI: 10.1007/s12529-011-9194-1. View

19.

Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M . I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res. 2010; 19(10):1419-27. PMC: 3031957. DOI: 10.1007/s11136-010-9757-7. View

20.

Jereczek-Fossa B, Santoro L, Alterio D, Franchi B, Fiore M, Fossati P . Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys. 2007; 68(2):403-15. DOI: 10.1016/j.ijrobp.2007.01.024. View